The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Interstitial Lung Disease Induced by Drugs and Radiation
Abstract
An ever-increasing number of drugs can reproduce variegated patterns of naturally occurring interstitial lung disease (ILD), including most forms of interstitial pneumonias, alveolar involvement and, rarely, vasculitis. Drugs in one therapeutic class may collectively produce the same pattern of involvement. A few drugs can produce more than one pattern of ILD. The diagnosis of drug-induced ILD (DI-ILD) essentially rests on the temporal association between exposure to the drug and the development of pulmonary infiltrates. The histopathological features of DI-ILD are generally consistent, rather than suggestive or specific to the drug etiology. Thus, the diagnosis of DI-ILD is mainly made by the meticulous exclusion of all other possible causes. Drug dechallenge produces measurable improvement in symptoms and imaging in the majority of patients, whereas corticosteroid therapy is indicated if symptoms are present or drug dechallenge is without an effect. Rechallenge is justified in a minority of patients, and is discouraged for diagnostic purposes only. Pneumotox® (www.pneumotox.com) provides updated information on drug-induced respiratory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Harris, W. H., & Rosenberg, A. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230808 · Cited by 896
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
Rossi, S. E., Erasmus, J. J., McAdams, H. P., Sporn, T. A., & Goodman, P. C. (2000) · RadioGraphics · doi:10.1148/radiographics.20.5.g00se081245 · Cited by 449
Transfusion-Related Acute Lung Injury: Report of a Clinical Look-Back Investigation
Kopko, P. M., Marshall, C. S., MacKenzie, M. R., Holland, P. V., & Popovsky, M. A. (2002) · JAMA · doi:10.1001/jama.287.15.1968 · Cited by 422
Leung, T. W. T., Lau, W.-Y., Ho, S. K. W., Ward, S. C., Chow, J. H. S., Chan, M. S. Y., Metreweli, C., Johnson, P. J., & Li, A. K. C. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00039-3 · Cited by 315
Keogh, K. A., & Specks, U. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00359-0 · Cited by 290
Beasley, M. B., Franks, T. J., Galvin, J. R., Gochuico, B., & Travis, W. D. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1064-afaop · Cited by 255
Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France
Gondouin, A., Manzoni, P., Ranfaing, E., Brun, J., Cadranel, J., Sadoun, D., Cordier, J. F., Depierre, A., & Dalphin, J. C. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09071463 · Cited by 244
Active Lung Fibrosis up to 17 Years after Chemotherapy with Carmustine (BCNU) in Childhood
O’Driscoll, B. R., Hasleton, P. S., Taylor, P. M., Poulter, L. W., Gattamaneni, H. R., & Woodcock, A. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008093230604 · Cited by 238
Rapidly Progressive Bronchiolitis Obliterans with Organizing Pneumonia
Cohen, A. J., King, T. E., & Downey, G. P. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.6.8004328 · Cited by 237
Comparison of registries of interstitial lung diseases in three European countries
Thomeer, M. J., Costabel, U., Rizzato, G., Poletti, V., & Demedts, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.18s320114 · Cited by 216
Chemotherapy-induced lung disease
Limper, A. H. (2004) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00123-0 · Cited by 206
Pulmonary complications of radiation therapy
Abratt, R. P., Morgan, G. W., Silvestri, G. A., & Willcox, P. A. (2004) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00126-6 · Cited by 160
Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone*
Ott, M. C., Khoór, A., Leventhal, J. P., Paterick, T. E., & Burger, C. D. (2003) · CHEST Journal · doi:10.1378/chest.123.2.646 · Cited by 156
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell, J. E., Phillips, T. M., & Schein, P. S. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.5.723 · Cited by 155
Drug-Induced Lung Disease: High-Resolution CT Findings
Ellis, S. J., Cleverley, J., & Müller, N. L. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.175.4.1751019 · Cited by 153
Wallis, J. P. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg101 · Cited by 132
The Impact of Intravenous Fat Emulsion Administration in Acute Lung Injury
Lekka, M. E., Liokatis, S., Nathanail, C., Galani, V., & Nakos, G. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-620oc · Cited by 126
Huggins, J. T., & Sahn, S. A. (2004) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00125-4 · Cited by 120
Bronchoalveolar lavage in drug-induced lung disease
Costabel, U., Uzaslan, E., & Guzman, J. (2004) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00143-6 · Cited by 117
Diagnostic Invasive Procedures in Diffuse Infiltrative Lung Diseases
Poletti, V. E., Chilosi, M., & Olivieri, D. (2004) · Respiration · doi:10.1159/000076670 · Cited by 101
Etiology and mechanisms of drug-induced lupus
Rubin, R. L. (1999) · Current Opinion in Rheumatology · doi:10.1097/00002281-199909000-00006 · Cited by 85
Asthma therapies and churg-strauss syndrome
Lilly, C. M., Churg, A., Lazarovich, M., PAUWELS, R. A., Hendeles, L., Rosenwasser, L. J., Ledford, D. K., & Wechsler, M. E. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.120854 · Cited by 74
Lee, K. S., Müller, N. L., Hale, V., Newell, J. D., Lynch, D. A., & Im, J.-G. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199501000-00009 · Cited by 73
Acute chest pain syndrome during bleomycin infusions
White, D. A., Schwartzberg, L. S., Kris, M. G., & Bosl, G. J. (1987) · Cancer · Cited by 52
Paterson, D. L., & Patel, A. (1998) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1998.tb04768.x · Cited by 48
Choi, H. K., Merkel, P. A., Tervaert, J. W. C., Black, R. M., McCluskey, R. T., & Niles, J. L. (1999) · Arthritis & Rheumatism · Cited by 47
Malhotra, A., Muse, V. V., & Mark, E. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmcpc030005 · Cited by 43
Radiation pneumonitis caused by yttrium-90 microspheres: radiologic findings.
Lin, M. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.162.6.8191985 · Cited by 38
Vascular leak syndrome associated with interleukin-2: chest radiographic manifestations.
Mann, H., Ward, J. H., & Samlowski, W. E. (1990) · Radiology · doi:10.1148/radiology.176.1.2353090 · Cited by 37
Pulmonary Nodules with the CT Halo Sign
Chouri-Pontarollo, N., Langin, T., Lantuéjoul, S., Coulomb, M., & Brambilla, C. (2002) · Respiration · doi:10.1159/000049381 · Cited by 17
Bronchiolitis obliterans following the ingestion of an Asian shrub leaf
Higenbottam, T. (1997) · Thorax · doi:10.1136/thx.52.2008.s68 · Cited by 14
Methotrexate pneumonitis in a patient with rheumatoid arthritis
Clearkin, R., Corris, P. A., & Thomas, S. H. L. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.863.603 · Cited by 11
Pseudosepsis Syndrome, Multiple-System Organ Failure, and Chronic Salicylate Intoxication
Matuschak, G. M. (1991) · CHEST Journal · doi:10.1378/chest.100.5.1188 · Cited by 8
Drug-Induced Respiratory Disease in Connective Tissue Diseases
Camus, P. (2004) · Technical report · doi:10.1016/s1571-5078(04)02013-6 · Cited by 4
Self-citationGravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Delaunay, M., Cadranel, J., Lusque, A., Meyer, N., Gounant, V., Moro-Sibilot, D., Michot, J.-M., Raimbourg, J., Girard, N., Guisier, F., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00050-2017 · Cited by 412
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
Matsuno, O. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-39 · Cited by 319
Consensus statement for the diagnosis and treatment of drug-induced lung injuries
Kubo, K., Azuma, A., Kanazawa, M., Kameda, H., Kusumoto, M., Genma, A., Saijo, Y., Sakai, F., Sugiyama, Y., Tatsumi, K., et al. (2013) · Respiratory Investigation · doi:10.1016/j.resinv.2013.09.001 · Cited by 279
Rituximab in severe, treatment-refractory interstitial lung disease
Keir, G. J., Maher, T. M., Ming, D., Abdullah, R., de Lauretis, A., Wickremasinghe, M., Nicholson, A. G., Hansell, D. M., Wells, A. U., & Renzoni, E. A. (2014) · Respirology · doi:10.1111/resp.12214 · Cited by 256
Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Metadata
- Authors
- Camus, P., Fanton, A., Bonniaud, P., Camus, C., & Foucher, P.
- Venue
- Respiration
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 71
- Issue
- 4
- Pages
- 301-326
- ISSN
- 0025-7931 (ISSN-L)
- 1423-0356
- OpenAlex
- W2161955176
- Cited by
- 393
- References
- 35
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.